美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

阿斯利康

200.47

-0.7400-0.37%

盤後：200.880.4100+0.20%18:48 EDT

成交量：141.44萬

成交額：2.84億

市值：3,109.29億

市盈率：30.65

高：201.80

開：201.44

低：199.99

收：201.21

52周最高：212.71

52周最低：132.32

股本：15.51億

流通股本：15.44億

量比：0.84

換手率：0.09%

股息：3.14

股息率：1.57%

每股收益(TTM):6.54

每股收益(LYR):6.54

淨資產收益率：22.84%

總資產收益率：8.19%

市淨率：6.39

市盈率(LYR):30.65

資料載入中...

總覽公司新聞資訊公告

「二次議價」猖狂，安徽藥價在「崩塌」

阿斯利康投了！生物製造完成億元融資！

阿斯利康罕見病新藥萬諾維獲批

萬諾維®在華獲批用於治療成人遺傳性轉甲狀腺素蛋白澱粉樣變性多發性神經病（ATTRv-PN）患者

超 70 億美元引進！阿斯利康小核酸療法國內獲批上市

丁香园 Insight 数据库

阿斯利康與第一三共ADC抗癌藥在華獲批第五項適應證

優赫得®在華獲批為首個用於既往在轉移性疾病階段經一種或一種以上內分泌治療進展的HER2低表達或超低表達乳腺癌患者的HER2靶向療法

阿斯利康「戈魯利單抗」國內申報上市，自免雙抗新藥劍指全身型重症肌無力

和鉑醫藥牽手百時美施貴寶：超60億合作背後的中國創新藥「逆襲」與全球研發新局

加科思與阿斯利康合作開發KRAS抑制劑交易總額突破20億美元

阿斯利康(AZN.US)自免雙抗「戈魯利單抗」在華申報上市

港股異動 | 加科思-B(01167)漲近5% 公司獲阿斯利康近20億美元BD大單公司稱首付比例均值偏上

阿斯利康肺癌試驗藥物組合未達到主要目標

环球市场播报

獲阿斯利康20億美元重金押注，加科思泛KRAS靶向藥成功出海，股價為何不漲反跌？

阿斯利康入局，Pan-KRAS抑制劑技術路線之爭開始逆轉

加科思與阿斯利康達成新合作；同仁堂方面發布致歉聲明 | 醫藥早參

每日经济新闻

加科思-B(01167)附屬與阿斯利康訂立許可與合作協議，以開發及商業化泛KRAS抑制劑JAB-23E73

智通财经网

默沙東(MRK.US)、施貴寶(BMY.US)等多家藥企同意下調美國藥價以換取特朗普政府關税豁免和政策支持

阿斯利康甲磺酸奧希替尼片啓動II期臨床適應症為不適合或拒絕化療的EGFR常見突變陽性III期不可切除NSCLC患者

荷聲科技完成Pre-A輪融資

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AZN/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"阿斯利康","latestPrice":200.47,"timestamp":1776369600000,"preClose":201.21,"halted":0,"volume":1414398,"hourTrading":{"tag":"盘后","latestPrice":200.88,"preClose":200.47,"latestTime":"18:48 EDT","volume":22446,"amount":4499491.490999999,"timestamp":1776379681879,"change":0.41,"changeRate":0.002045,"amplitude":0.009487},"delay":0,"changeRate":-0.0036777496148303218,"floatShares":1544000000,"shares":1551000000,"eps":6.54,"marketStatus":"盤後交易","change":-0.74,"latestTime":"04-16 19:11:40 EDT","open":201.44,"high":201.8,"low":199.99,"amount":283864883.79078,"amplitude":0.008996,"askPrice":201.27,"askSize":1,"bidPrice":198.48,"bidSize":20,"shortable":3,"etf":0,"ttmEps":6.54,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1776384000000},"marketStatusCode":4,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NYSE","adjPreClose":201.21,"dividendRate":0.015658,"preHourTrading":{"tag":"盘前","latestPrice":201.47,"preClose":201.21,"latestTime":"09:29 EDT","volume":11605,"amount":2328724.5201,"timestamp":1776346199148,"change":0.26,"changeRate":0.001292,"amplitude":0.012922},"postHourTrading":{"tag":"盘后","latestPrice":200.88,"preClose":200.47,"latestTime":"18:48 EDT","volume":22446,"amount":4499491.490999999,"timestamp":1776379681879,"change":0.41,"changeRate":0.002045,"amplitude":0.009487},"volumeRatio":0.837438,"impliedVol":0.318,"impliedVolPercentile":0.876},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","floatShares":1544000000,"roa":"8.19%","roe":"22.84%","lyrEps":6.54,"volumeRatio":0.837438,"shares":1551000000,"dividePrice":3.1389,"high":201.8,"amplitude":0.008996,"preClose":201.21,"low":199.99,"week52Low":132.32,"pbRate":"6.39","psRate":"5.29","week52High":212.71,"institutionHeld":0,"latestPrice":200.47,"committee":0.904762,"eps":6.54,"divideRate":0.015658,"volume":1414398,"delay":0,"ttmEps":6.54,"open":201.44,"prevYearClose":183.86,"prevWeekClose":204.03,"prevMonthClose":197.22,"prevQuarterClose":197.22,"fiveDayClose":204.99,"twentyDayClose":188.42,"sixtyDayClose":179.88,"earningDate":1777392000000,"earningTime":"盘前","dividendPayoutRate":0.4744743415493694,"dividendFrequency":"S","dividendGrowthYears":1,"dividendGrowthRate":2.13,"fiveYearAvgDividendRate":0.01800023813182617},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZN\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"AZN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":2.53,"defaultRemindTime":1777449600000,"name":null,"time":"盤前","dateTimestamp":1777435200000,"actualEps":null},{"date":"2026-02-20","symbol":"AZN","amount":2.17,"announcedDate":"2026-02-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-23"},{"market":"US","date":"2026-02-10","symbol":"AZN","fiscalQuarterEnding":"2025/12","expectedEps":2.18,"name":null,"time":"盤前","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"pre","actualEps":2.1},{"market":"US","date":"2026-02-02","symbol":"AZN","defaultRemindTime":1770042600000,"type":"split","dateTimestamp":1770008400000,"forFactor":2,"toFactor":1,"ratio":2},{"market":"US","date":"2025-11-06","symbol":"AZN","fiscalQuarterEnding":"2025/09","expectedEps":1.14,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":1.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZN\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-03-20","value":0.93,"currency":"USD"},{"executeDate":"2017-08-09","recordDate":"2017-08-11","paymentDate":"2017-09-11","value":0.44,"currency":"USD"},{"executeDate":"2018-02-15","recordDate":"2018-02-16","paymentDate":"2018-03-19","value":0.93,"currency":"USD"},{"executeDate":"2018-08-09","recordDate":"2018-08-10","paymentDate":"2018-09-10","value":0.44,"currency":"USD"},{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-27","value":0.93,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1775880000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZN","date":"2026-04-15","current":30.652905,"percent":0.258833,"low":-196.839437,"twenty":29.407351,"median":34.711793,"eighty":50.526805,"high":1968.240717,"avg":98.489887,"sd":365.466144,"marketCap":310932657305.97},"quantilePoints":[{"date":"2021-04-16","current":41.895286,"twenty":33.808324,"median":43.829519,"eighty":64.272386,"marketCap":133897332132.29},{"date":"2021-04-23","current":43.015928,"twenty":33.808324,"median":43.622491,"eighty":64.049177,"marketCap":137478904953.89},{"date":"2021-04-30","current":35.178221,"twenty":33.808324,"median":43.552363,"eighty":63.927524,"marketCap":139903784314.35},{"date":"2021-05-07","current":35.713855,"twenty":33.808324,"median":43.372927,"eighty":63.927524,"marketCap":142034002903.86},{"date":"2021-05-14","current":36.578305,"twenty":33.808324,"median":43.217296,"eighty":63.927524,"marketCap":145471921978.13},{"date":"2021-05-21","current":38.04253,"twenty":33.808324,"median":43.055022,"eighty":63.927524,"marketCap":151295142362.51},{"date":"2021-05-28","current":37.667421,"twenty":33.808324,"median":42.981334,"eighty":63.927524,"marketCap":149803331492.43},{"date":"2021-06-04","current":37.668709,"twenty":33.808324,"median":42.916976,"eighty":63.927524,"marketCap":149808456584.88},{"date":"2021-06-11","current":38.832052,"twenty":33.808324,"median":42.773046,"eighty":63.927524,"marketCap":154435068990.32},{"date":"2021-06-18","current":38.18588,"twenty":33.808324,"median":42.622329,"eighty":63.927524,"marketCap":151865244858.85},{"date":"2021-06-25","current":39.023576,"twenty":33.808324,"median":42.398874,"eighty":63.927524,"marketCap":155196763903.69},{"date":"2021-07-02","current":39.976605,"twenty":33.808324,"median":42.174589,"eighty":63.927524,"marketCap":158986959728.24},{"date":"2021-07-09","current":39.480288,"twenty":33.808324,"median":42.080378,"eighty":63.927524,"marketCap":157013104025.95},{"date":"2021-07-16","current":37.956603,"twenty":33.808324,"median":41.899376,"eighty":63.927524,"marketCap":150953410117.19},{"date":"2021-07-23","current":45.441176,"twenty":33.808324,"median":41.888722,"eighty":63.927524,"marketCap":180719559415.33},{"date":"2021-07-30","current":47.231592,"twenty":33.810018,"median":41.892004,"eighty":63.861793,"marketCap":178110332974.09},{"date":"2021-08-06","current":46.469553,"twenty":33.810018,"median":41.892004,"eighty":63.713835,"marketCap":175236684168.41},{"date":"2021-08-13","current":47.972744,"twenty":33.810018,"median":41.892004,"eighty":63.551982,"marketCap":180905220248.64},{"date":"2021-08-20","current":48.844093,"twenty":33.810018,"median":41.892004,"eighty":63.422693,"marketCap":184191075201.21},{"date":"2021-08-27","current":48.365293,"twenty":33.810018,"median":41.892004,"eighty":62.883701,"marketCap":182385516153.02},{"date":"2021-09-03","current":48.463129,"twenty":33.811774,"median":41.895286,"eighty":62.612474,"marketCap":182754457617.81},{"date":"2021-09-10","current":46.494,"twenty":33.811774,"median":41.895286,"eighty":62.43589,"marketCap":175328870596.71},{"date":"2021-09-17","current":45.556592,"twenty":33.811774,"median":41.895286,"eighty":61.949531,"marketCap":171793907663.64},{"date":"2021-09-24","current":49.669587,"twenty":33.811774,"median":41.895286,"eighty":61.607974,"marketCap":187304013407.33},{"date":"2021-10-01","current":48.824353,"twenty":33.811774,"median":41.895286,"eighty":61.248398,"marketCap":184116632093.75},{"date":"2021-10-08","current":49.800513,"twenty":33.811774,"median":41.895286,"eighty":61.020009,"marketCap":187797735584.04},{"date":"2021-10-15","current":49.71937,"twenty":33.811774,"median":41.895286,"eighty":60.739134,"marketCap":187491745853.75},{"date":"2021-10-22","current":50.871053,"twenty":33.811774,"median":41.895286,"eighty":60.537147,"marketCap":191834739729.65},{"date":"2021-10-29","current":51.128224,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":192804535774.89},{"date":"2021-11-05","current":51.586876,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":194534108269.15},{"date":"2021-11-12","current":124.32333,"twenty":33.81353,"median":41.917192,"eighty":60.445661,"marketCap":182879619363.67},{"date":"2021-11-19","current":120.23438,"twenty":33.81353,"median":42.14268,"eighty":60.685883,"marketCap":176864773031.09},{"date":"2021-11-26","current":117.962901,"twenty":33.81353,"median":42.190627,"eighty":60.88723,"marketCap":173523426730.59},{"date":"2021-12-03","current":114.058101,"twenty":33.81353,"median":42.459679,"eighty":61.11746,"marketCap":167779466800.21},{"date":"2021-12-10","current":114.181064,"twenty":33.81353,"median":42.699465,"eighty":61.452265,"marketCap":167960345018.33},{"date":"2021-12-17","current":118.980811,"twenty":33.81353,"median":42.837881,"eighty":61.891111,"marketCap":175020772922.72},{"date":"2021-12-23","current":121.330793,"twenty":33.81353,"median":42.933402,"eighty":62.081355,"marketCap":178477596827.59},{"date":"2021-12-31","current":123.748715,"twenty":33.81353,"median":43.007672,"eighty":62.499235,"marketCap":182034359116.88},{"date":"2022-01-07","current":120.050561,"twenty":33.815286,"median":43.097412,"eighty":62.953761,"marketCap":176594376318.68},{"date":"2022-01-14","current":123.058267,"twenty":33.815286,"median":43.234717,"eighty":63.424083,"marketCap":181018710009.44},{"date":"2022-01-21","current":124.994373,"twenty":33.815286,"median":43.372927,"eighty":63.548212,"marketCap":183866722078.34},{"date":"2022-01-28","current":123.976416,"twenty":33.815286,"median":43.552363,"eighty":63.706505,"marketCap":182369309247.62},{"date":"2022-02-04","current":118.184057,"twenty":33.815286,"median":43.622491,"eighty":63.860585,"marketCap":173848748288.24},{"date":"2022-02-11","current":1601.026247,"twenty":33.817042,"median":43.82776,"eighty":64.00879,"marketCap":179314939563.19},{"date":"2022-02-18","current":1654.401018,"twenty":33.817042,"median":43.939798,"eighty":64.169686,"marketCap":185292914010.65},{"date":"2022-02-25","current":1668.738174,"twenty":33.817042,"median":44.078325,"eighty":64.295473,"marketCap":186898675368.11},{"date":"2022-03-04","current":1586.663703,"twenty":33.817042,"median":44.224518,"eighty":64.600266,"marketCap":177706334684.76},{"date":"2022-03-11","current":1675.474001,"twenty":33.817042,"median":44.467018,"eighty":65.166625,"marketCap":187653088130.53},{"date":"2022-03-18","current":1738.306661,"twenty":33.817042,"median":44.572948,"eighty":65.784088,"marketCap":194690345992.99},{"date":"2022-03-25","current":1795.841809,"twenty":33.817042,"median":44.572948,"eighty":66.489581,"marketCap":201134282573.26},{"date":"2022-04-01","current":1827.083488,"twenty":33.817042,"median":44.572948,"eighty":66.698379,"marketCap":204633350610.8},{"date":"2022-04-08","current":1968.240717,"twenty":33.817042,"median":44.599854,"eighty":66.956295,"marketCap":220442960330.62},{"date":"2022-04-14","current":1903.633793,"twenty":33.817042,"median":44.664609,"eighty":67.127776,"marketCap":213206984758.84},{"date":"2022-04-22","current":1827.31022,"twenty":33.817042,"median":45.008047,"eighty":67.494417,"marketCap":204658744606.77},{"date":"2022-04-29","current":-195.561143,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":207881494412.78},{"date":"2022-05-06","current":-186.047843,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":197768857946.09},{"date":"2022-05-13","current":-183.445869,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":195002958947.03},{"date":"2022-05-20","current":-190.668769,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202680901868.49},{"date":"2022-05-27","current":-194.54477,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":206801090657.37},{"date":"2022-06-03","current":-190.374978,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202368602400.22},{"date":"2022-06-10","current":-176.891963,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":188036156437.33},{"date":"2022-06-17","current":-176.59081,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":187716030487.33},{"date":"2022-06-24","current":-193.054847,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205217301659.23},{"date":"2022-07-01","current":-188.578174,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200458598457.74},{"date":"2022-07-08","current":-193.728763,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205933674494.87},{"date":"2022-07-15","current":-192.228519,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204338915909.36},{"date":"2022-07-22","current":-188.718222,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200607469952.86},{"date":"2022-07-29","current":-163.162978,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204443212506.84},{"date":"2022-08-05","current":-161.84855,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":202796233583.46},{"date":"2022-08-12","current":-160.589567,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":201218726783.29},{"date":"2022-08-19","current":-164.33585,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":205912819247.31},{"date":"2022-08-26","current":-165.535736,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":207416276963.04},{"date":"2022-09-02","current":-151.980645,"twenty":33.793274,"median":45.556592,"eighty":67.618433,"marketCap":190431747964.03},{"date":"2022-09-09","current":-150.350821,"twenty":33.759854,"median":45.556592,"eighty":67.618433,"marketCap":188389579323.08},{"date":"2022-09-16","current":-142.971469,"twenty":33.462713,"median":45.556592,"eighty":67.618433,"marketCap":179143250929.75},{"date":"2022-09-23","current":-135.412757,"twenty":33.234819,"median":45.556592,"eighty":67.618433,"marketCap":169672185276.98},{"date":"2022-09-30","current":-137.024975,"twenty":33.070312,"median":45.556592,"eighty":67.618433,"marketCap":171692293015.61},{"date":"2022-10-07","current":-137.934582,"twenty":32.990313,"median":45.556592,"eighty":67.618433,"marketCap":172832030829.71},{"date":"2022-10-14","current":-136.189836,"twenty":32.851802,"median":45.556592,"eighty":67.618433,"marketCap":170645864409.42},{"date":"2022-10-21","current":-134.729179,"twenty":32.794598,"median":45.556592,"eighty":67.618433,"marketCap":168815662212.36},{"date":"2022-10-28","current":-145.085703,"twenty":32.578746,"median":45.556592,"eighty":67.618433,"marketCap":181792385725.21},{"date":"2022-11-04","current":-150.046253,"twenty":32.441126,"median":45.556592,"eighty":67.618433,"marketCap":188007955286.73},{"date":"2022-11-11","current":94.735808,"twenty":32.406054,"median":46.033505,"eighty":67.825263,"marketCap":193261049543.38},{"date":"2022-11-18","current":98.881438,"twenty":32.406054,"median":46.253226,"eighty":68.270745,"marketCap":201718134504.01},{"date":"2022-11-25","current":100.570487,"twenty":32.406054,"median":46.494,"eighty":68.630373,"marketCap":205163794032.47},{"date":"2022-12-02","current":104.001851,"twenty":32.406054,"median":46.662739,"eighty":69.183829,"marketCap":212163775968.3},{"date":"2022-12-09","current":106.087706,"twenty":32.406054,"median":47.149871,"eighty":69.716808,"marketCap":216418920541.74},{"date":"2022-12-16","current":102.978508,"twenty":32.406054,"median":47.231592,"eighty":77.51575,"marketCap":210076156888.69},{"date":"2022-12-23","current":102.942288,"twenty":32.406054,"median":47.744626,"eighty":80.277721,"marketCap":210002267642.7},{"date":"2022-12-30","current":102.667462,"twenty":32.406054,"median":47.889649,"eighty":84.998822,"marketCap":209441622638.71},{"date":"2023-01-06","current":107.816944,"twenty":32.458836,"median":48.074276,"eighty":86.203785,"marketCap":219946565887.33},{"date":"2023-01-13","current":108.069807,"twenty":32.750787,"median":48.137803,"eighty":87.690545,"marketCap":220462406785.54},{"date":"2023-01-20","current":105.346185,"twenty":32.842448,"median":48.225012,"eighty":88.132026,"marketCap":214906218177.77},{"date":"2023-01-27","current":99.91328,"twenty":32.990313,"median":48.365293,"eighty":89.493625,"marketCap":203823092868.29},{"date":"2023-02-03","current":97.194847,"twenty":33.091636,"median":48.590919,"eighty":89.958492,"marketCap":198277488061.49},{"date":"2023-02-10","current":64.79374,"twenty":34.704276,"median":48.67565,"eighty":90.227834,"marketCap":213041815934.3},{"date":"2023-02-17","current":64.947931,"twenty":34.925603,"median":48.824353,"eighty":90.227834,"marketCap":213548799709.69},{"date":"2023-02-24","current":62.505092,"twenty":34.952202,"median":48.879329,"eighty":90.227834,"marketCap":205516742935.99},{"date":"2023-03-03","current":60.884824,"twenty":35.166348,"median":49.034331,"eighty":90.227834,"marketCap":200189300543.79},{"date":"2023-03-10","current":60.817416,"twenty":35.244416,"median":49.259346,"eighty":90.227834,"marketCap":199967660996.94},{"date":"2023-03-17","current":62.038789,"twenty":35.50748,"median":49.397527,"eighty":90.227834,"marketCap":203983536730.65},{"date":"2023-03-24","current":63.847982,"twenty":35.636896,"median":49.622888,"eighty":90.227834,"marketCap":209932167388.35},{"date":"2023-03-31","current":65.498173,"twenty":35.705258,"median":49.69358,"eighty":90.221194,"marketCap":215357992309.98},{"date":"2023-04-06","current":68.570831,"twenty":35.757541,"median":49.714558,"eighty":90.221194,"marketCap":225460889410.27},{"date":"2023-04-14","current":70.200873,"twenty":35.964313,"median":49.945228,"eighty":90.227834,"marketCap":230820471067.89},{"date":"2023-04-21","current":71.517248,"twenty":36.054882,"median":50.706874,"eighty":90.227834,"marketCap":235148709402.74},{"date":"2023-04-27","current":48.542146,"twenty":36.18562,"median":50.911319,"eighty":90.227834,"marketCap":228390801103.1},{"date":"2023-05-05","current":49.347014,"twenty":36.268071,"median":50.945363,"eighty":90.234475,"marketCap":232177702207.76},{"date":"2023-05-12","current":49.504739,"twenty":36.37963,"median":50.979408,"eighty":90.241115,"marketCap":232919796188.45},{"date":"2023-05-19","current":49.107772,"twenty":36.442091,"median":51.05333,"eighty":90.273874,"marketCap":231052066290.14},{"date":"2023-05-26","current":47.846336,"twenty":36.591375,"median":51.060903,"eighty":90.299991,"marketCap":225117008406.37},{"date":"2023-06-02","current":48.462782,"twenty":36.80131,"median":51.068476,"eighty":90.326109,"marketCap":228017386013.05},{"date":"2023-06-09","current":48.413705,"twenty":36.956644,"median":51.09835,"eighty":90.352226,"marketCap":227786482533.35},{"date":"2023-06-16","current":49.548607,"twenty":37.011895,"median":51.09835,"eighty":90.352226,"marketCap":233126199438.55},{"date":"2023-06-23","current":47.927025,"twenty":37.145966,"median":51.128224,"eighty":90.378344,"marketCap":225496652662.89},{"date":"2023-06-29","current":46.686861,"twenty":37.277576,"median":51.128224,"eighty":90.378344,"marketCap":219661682991.5},{"date":"2023-07-07","current":42.266477,"twenty":37.450916,"median":51.137896,"eighty":90.382517,"marketCap":198863776215.19},{"date":"2023-07-14","current":44.543915,"twenty":37.668194,"median":51.147569,"eighty":90.38669,"marketCap":209579116648.77},{"date":"2023-07-20","current":45.272526,"twenty":37.899674,"median":51.147569,"eighty":90.38669,"marketCap":213007237009.48},{"date":"2023-07-28","current":46.8505,"twenty":38.043422,"median":51.198971,"eighty":90.390862,"marketCap":220431604774.28},{"date":"2023-08-04","current":34.891689,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":215037480780.58},{"date":"2023-08-11","current":35.26449,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":217335048660.17},{"date":"2023-08-18","current":34.16614,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210565921407.54},{"date":"2023-08-25","current":33.869471,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":208737548997.49},{"date":"2023-09-01","current":34.101255,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210166031129.92},{"date":"2023-09-08","current":34.014193,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":209629465144.03},{"date":"2023-09-15","current":34.144205,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":210430732865.46},{"date":"2023-09-22","current":34.173978,"twenty":38.142274,"median":51.271456,"eighty":90.405762,"marketCap":210614226640.52},{"date":"2023-09-29","current":34.077187,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":210017704350},{"date":"2023-10-06","current":33.461697,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":206224433900},{"date":"2023-10-13","current":33.700939,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":207698886830.05},{"date":"2023-10-20","current":31.854117,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":196316921973.67},{"date":"2023-10-27","current":30.825604,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":189978199121.01},{"date":"2023-11-03","current":31.446977,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":193807722775.81},{"date":"2023-11-10","current":32.576944,"twenty":38.185708,"median":51.294062,"eighty":90.41603,"marketCap":192073660849.91},{"date":"2023-11-17","current":33.492327,"twenty":38.038501,"median":51.294062,"eighty":90.41603,"marketCap":197470761267.37},{"date":"2023-11-24","current":33.532656,"twenty":37.946854,"median":51.294062,"eighty":90.41603,"marketCap":197708536718.25},{"date":"2023-12-01","current":33.915355,"twenty":37.668451,"median":51.294062,"eighty":90.41603,"marketCap":199964933886.19},{"date":"2023-12-08","current":33.457568,"twenty":37.464611,"median":51.286265,"eighty":90.415594,"marketCap":197265816339.95},{"date":"2023-12-15","current":34.186234,"twenty":37.210418,"median":51.286265,"eighty":90.415594,"marketCap":201562040512.73},{"date":"2023-12-22","current":34.744053,"twenty":37.103714,"median":51.286265,"eighty":90.415594,"marketCap":204850936396.91},{"date":"2023-12-29","current":35.502272,"twenty":37.004613,"median":51.294062,"eighty":90.41603,"marketCap":209321397367.75},{"date":"2024-01-05","current":35.915235,"twenty":36.741256,"median":51.301859,"eighty":90.416466,"marketCap":211756222293.47},{"date":"2024-01-12","current":36.28455,"twenty":36.334148,"median":51.301859,"eighty":90.416466,"marketCap":213933708276.37},{"date":"2024-01-19","current":35.054357,"twenty":36.147608,"median":51.316432,"eighty":90.416903,"marketCap":206680482585.36},{"date":"2024-01-26","current":35.21195,"twenty":35.750631,"median":51.301859,"eighty":90.416466,"marketCap":207609659830.59},{"date":"2024-02-02","current":34.611292,"twenty":35.488516,"median":51.301859,"eighty":90.416466,"marketCap":204068178014.97},{"date":"2024-02-09","current":32.042332,"twenty":35.415951,"median":51.301859,"eighty":90.416466,"marketCap":190812082322.82},{"date":"2024-02-16","current":33.046703,"twenty":35.234976,"median":51.301859,"eighty":90.416466,"marketCap":196793117826.02},{"date":"2024-02-23","current":33.625836,"twenty":35.160006,"median":51.301859,"eighty":90.416466,"marketCap":200241851316.37},{"date":"2024-03-01","current":33.150124,"twenty":34.950737,"median":51.294062,"eighty":90.41603,"marketCap":197408989034.17},{"date":"2024-03-08","current":33.961877,"twenty":34.884115,"median":51.294062,"eighty":90.41603,"marketCap":202242978023.88},{"date":"2024-03-15","current":34.178971,"twenty":34.843983,"median":51.294062,"eighty":90.41603,"marketCap":203535777995.74},{"date":"2024-03-22","current":34.569497,"twenty":34.797981,"median":51.294062,"eighty":90.41603,"marketCap":205861353801.33},{"date":"2024-03-28","current":35.138443,"twenty":34.738617,"median":51.294062,"eighty":90.41603,"marketCap":209249428257.93},{"date":"2024-04-05","current":35.017877,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":208531458010.87},{"date":"2024-04-12","current":36.040239,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":214619626779.03},{"date":"2024-04-19","current":35.516317,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":211499662791.19},{"date":"2024-04-26","current":36.676755,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":232200540199.91},{"date":"2024-05-03","current":36.8693,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":233419536058.18},{"date":"2024-05-10","current":37.90429,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":239972059656.37},{"date":"2024-05-17","current":37.573079,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":237875168240.39},{"date":"2024-05-24","current":38.271406,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":242296270130.04},{"date":"2024-05-31","current":38.035274,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":240801317006.26},{"date":"2024-06-07","current":39.311051,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":248878266840.98},{"date":"2024-06-14","current":39.080088,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":247416040543.47},{"date":"2024-06-21","current":38.711485,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":245082412423.47},{"date":"2024-06-28","current":38.258325,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":242213457601.51},{"date":"2024-07-05","current":37.686159,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":238591075664.77},{"date":"2024-07-12","current":38.775783,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":245489481019.61},{"date":"2024-07-15","current":38.484698,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":243646624421.22},{"date":"2024-08-02","current":38.76335,"twenty":34.59882,"median":51.492254,"eighty":90.59886,"marketCap":249635972195.12},{"date":"2024-08-09","current":38.89894,"twenty":34.59882,"median":51.294062,"eighty":90.59886,"marketCap":250509172617.5},{"date":"2024-08-16","current":40.397147,"twenty":34.59882,"median":51.060903,"eighty":90.59886,"marketCap":260157622811.64},{"date":"2024-08-23","current":41.20613,"twenty":34.59882,"median":50.717669,"eighty":90.59886,"marketCap":265367483505.69},{"date":"2024-08-30","current":42.055252,"twenty":34.59882,"median":50.035509,"eighty":90.59886,"marketCap":270835826209.18},{"date":"2024-09-06","current":40.0627,"twenty":34.59882,"median":49.699751,"eighty":90.59886,"marketCap":258003788372.74},{"date":"2024-09-13","current":37.541027,"twenty":34.59882,"median":49.61335,"eighty":90.59886,"marketCap":241764208376.59},{"date":"2024-09-20","current":37.638672,"twenty":34.59882,"median":49.509177,"eighty":90.59886,"marketCap":242393042178.33},{"date":"2024-09-27","current":37.625615,"twenty":34.59882,"median":49.286663,"eighty":90.59886,"marketCap":242308957210.11},{"date":"2024-10-04","current":37.048339,"twenty":34.59882,"median":49.111103,"eighty":90.59886,"marketCap":238591303207.03},{"date":"2024-10-11","current":36.952592,"twenty":34.59882,"median":48.955607,"eighty":90.59886,"marketCap":237974690511.11},{"date":"2024-10-18","current":37.277326,"twenty":34.59882,"median":48.824043,"eighty":90.59886,"marketCap":240065978538.81},{"date":"2024-10-25","current":36.219041,"twenty":34.59882,"median":48.705135,"eighty":90.59886,"marketCap":233250622910.59},{"date":"2024-10-31","current":34.214563,"twenty":34.574738,"median":48.556466,"eighty":90.59886,"marketCap":220341789337.11},{"date":"2024-11-08","current":30.94958,"twenty":34.409381,"median":48.405215,"eighty":90.61471,"marketCap":199315297141.26},{"date":"2024-11-15","current":30.278774,"twenty":34.310083,"median":48.308272,"eighty":90.61471,"marketCap":196660634447.86},{"date":"2024-11-22","current":31.513145,"twenty":34.186234,"median":48.222861,"eighty":90.61471,"marketCap":204677872404.93},{"date":"2024-11-29","current":32.112113,"twenty":34.16614,"median":48.127581,"eighty":90.61471,"marketCap":208568177906.67},{"date":"2024-12-06","current":32.437834,"twenty":34.130516,"median":47.956432,"eighty":90.61471,"marketCap":210683725873.77},{"date":"2024-12-13","current":31.735912,"twenty":34.077187,"median":47.36104,"eighty":90.61471,"marketCap":206124752986.75},{"date":"2024-12-20","current":30.747177,"twenty":33.965862,"median":47.158831,"eighty":90.61471,"marketCap":199702915335.92},{"date":"2024-12-27","current":31.253559,"twenty":33.915355,"median":46.947642,"eighty":90.61471,"marketCap":202991871173.56},{"date":"2025-01-03","current":31.292576,"twenty":33.861252,"median":46.643867,"eighty":90.61471,"marketCap":203245281002.46},{"date":"2025-01-10","current":32.234446,"twenty":33.727001,"median":46.406597,"eighty":90.65359,"marketCap":209362728493.97},{"date":"2025-01-17","current":31.94661,"twenty":33.648774,"median":45.807185,"eighty":90.65359,"marketCap":207493237604.76},{"date":"2025-01-24","current":32.550101,"twenty":33.596764,"median":45.422812,"eighty":90.65359,"marketCap":211412903531.46},{"date":"2025-01-31","current":33.75602,"twenty":33.533107,"median":44.889475,"eighty":90.65359,"marketCap":219245348015.01},{"date":"2025-02-07","current":31.815023,"twenty":33.517373,"median":44.556858,"eighty":90.65359,"marketCap":223818687137.12},{"date":"2025-02-14","current":32.356027,"twenty":33.43473,"median":43.745721,"eighty":90.65359,"marketCap":227624649448.94},{"date":"2025-02-21","current":32.60623,"twenty":33.370464,"median":43.206289,"eighty":90.41603,"marketCap":229384833994.16},{"date":"2025-02-28","current":33.297502,"twenty":33.297026,"median":42.86189,"eighty":90.196276,"marketCap":234247926833.79},{"date":"2025-03-07","current":34.342579,"twenty":33.296549,"median":42.266477,"eighty":89.763533,"marketCap":241600044097.11},{"date":"2025-03-14","current":34.223161,"twenty":33.289955,"median":41.916906,"eighty":89.650259,"marketCap":240759931866.61},{"date":"2025-03-21","current":33.174158,"twenty":33.275366,"median":41.821537,"eighty":89.650259,"marketCap":233380202105.67},{"date":"2025-03-28","current":32.611493,"twenty":33.192075,"median":41.337415,"eighty":89.650259,"marketCap":229421855281.37},{"date":"2025-04-04","current":31.260761,"twenty":33.125053,"median":41.199067,"eighty":89.650259,"marketCap":219919458662.82},{"date":"2025-04-11","current":28.594151,"twenty":33.037318,"median":41.064599,"eighty":89.636216,"marketCap":201159849729.73},{"date":"2025-04-17","current":29.581448,"twenty":33.006368,"median":40.989973,"eighty":88.809353,"marketCap":208105481337.82},{"date":"2025-04-25","current":30.491371,"twenty":32.783239,"median":40.827536,"eighty":71.444046,"marketCap":214506794307},{"date":"2025-05-02","current":28.51286,"twenty":32.645488,"median":40.694901,"eighty":70.207612,"marketCap":221601942295.02},{"date":"2025-05-09","current":27.170306,"twenty":32.566207,"median":40.439632,"eighty":69.395159,"marketCap":211167616410.88},{"date":"2025-05-16","current":27.370887,"twenty":32.435824,"median":40.15966,"eighty":69.006146,"marketCap":212726533009.73},{"date":"2025-05-23","current":27.957316,"twenty":32.322678,"median":39.976605,"eighty":68.630373,"marketCap":217284264528.17},{"date":"2025-05-30","current":28.851396,"twenty":32.241293,"median":39.748319,"eighty":68.346102,"marketCap":224233046530.51},{"date":"2025-06-06","current":29.243478,"twenty":32.08057,"median":39.714328,"eighty":68.12701,"marketCap":227280309755.04},{"date":"2025-06-13","current":29.77937,"twenty":32.02311,"median":39.480288,"eighty":67.717165,"marketCap":231445260111.41},{"date":"2025-06-20","current":27.833441,"twenty":31.960861,"median":39.343784,"eighty":67.509122,"marketCap":216321500558.44},{"date":"2025-06-27","current":28.009906,"twenty":31.854159,"median":39.123141,"eighty":67.186585,"marketCap":217692984791.35},{"date":"2025-07-03","current":27.802257,"twenty":31.80714,"median":39.024693,"eighty":66.962775,"marketCap":216079143172.01},{"date":"2025-07-11","current":28.279428,"twenty":31.714807,"median":38.870711,"eighty":66.731474,"marketCap":219787712681.75},{"date":"2025-07-18","current":27.545673,"twenty":31.491876,"median":38.769566,"eighty":66.520788,"marketCap":214084974334.11},{"date":"2025-07-25","current":29.172645,"twenty":31.404097,"median":38.671164,"eighty":66.049074,"marketCap":226729805296.57},{"date":"2025-08-01","current":27.450076,"twenty":31.285387,"median":38.59711,"eighty":65.682834,"marketCap":227698382305.18},{"date":"2025-08-08","current":27.389883,"twenty":31.239878,"median":38.507183,"eighty":65.361166,"marketCap":227199076245.22},{"date":"2025-08-15","current":29.344859,"twenty":31.148953,"median":38.320682,"eighty":64.905305,"marketCap":243415608857.5},{"date":"2025-08-22","current":30.340268,"twenty":31.053244,"median":38.195008,"eighty":64.339484,"marketCap":251672525941.34},{"date":"2025-08-29","current":29.776335,"twenty":30.79086,"median":38.076901,"eighty":64.10097,"marketCap":246994698975.95},{"date":"2025-09-05","current":30.363153,"twenty":30.666228,"median":38.015696,"eighty":63.603755,"marketCap":251862352359.71},{"date":"2025-09-12","current":29.927337,"twenty":30.393617,"median":37.932984,"eighty":63.299139,"marketCap":248247269052.01},{"date":"2025-09-19","current":28.645466,"twenty":30.311903,"median":37.873977,"eighty":62.462983,"marketCap":237614147208.25},{"date":"2025-09-26","current":27.449429,"twenty":30.181258,"median":37.760202,"eighty":61.578433,"marketCap":227693019996},{"date":"2025-10-03","current":31.722006,"twenty":30.157275,"median":37.691978,"eighty":61.182288,"marketCap":263134040754.4},{"date":"2025-10-10","current":31.779765,"twenty":30.157275,"median":37.646986,"eighty":60.857861,"marketCap":263613143515.1},{"date":"2025-10-17","current":31.527671,"twenty":30.157275,"median":37.61203,"eighty":59.786203,"marketCap":261522031415.6},{"date":"2025-10-24","current":31.210908,"twenty":30.157275,"median":37.512557,"eighty":58.437339,"marketCap":258894485628.07},{"date":"2025-10-31","current":30.645781,"twenty":30.157275,"median":37.385642,"eighty":57.126635,"marketCap":254206749846.85},{"date":"2025-11-07","current":27.892437,"twenty":30.05398,"median":37.224851,"eighty":56.544377,"marketCap":262161018116.77},{"date":"2025-11-14","current":29.465932,"twenty":29.907939,"median":37.187776,"eighty":55.975699,"marketCap":276950296874.71},{"date":"2025-11-21","current":29.849588,"twenty":29.82382,"median":37.124826,"eighty":55.19873,"marketCap":280556277388.82},{"date":"2025-11-28","current":30.557443,"twenty":29.82382,"median":37.050904,"eighty":54.957642,"marketCap":287209401693.86},{"date":"2025-12-05","current":29.941564,"twenty":29.800469,"median":36.962015,"eighty":54.235905,"marketCap":281420767708.56},{"date":"2025-12-12","current":29.764018,"twenty":29.784883,"median":36.821675,"eighty":53.767507,"marketCap":279752003848.48},{"date":"2025-12-19","current":30.21406,"twenty":29.784883,"median":36.62753,"eighty":53.285774,"marketCap":283981945416.43},{"date":"2025-12-26","current":30.509855,"twenty":29.784883,"median":36.3957,"eighty":53.285774,"marketCap":286762127698.97},{"date":"2026-01-02","current":30.214527,"twenty":29.784883,"median":36.24741,"eighty":53.285774,"marketCap":283986338067.91},{"date":"2026-01-09","current":31.507727,"twenty":29.784883,"median":36.112299,"eighty":53.017252,"marketCap":296141129485.56},{"date":"2026-01-16","current":31.047495,"twenty":29.784883,"median":35.820385,"eighty":52.672067,"marketCap":291815406526.34},{"date":"2026-01-23","current":30.236208,"twenty":29.777549,"median":35.710806,"eighty":52.385113,"marketCap":284190118048.85},{"date":"2026-01-30","current":30.915654,"twenty":29.777549,"median":35.485077,"eighty":51.606024,"marketCap":290576235840.63},{"date":"2026-02-06","current":31.509944,"twenty":29.777549,"median":35.416911,"eighty":50.936066,"marketCap":296161965984.29},{"date":"2026-02-13","current":31.237199,"twenty":29.777549,"median":35.301381,"eighty":50.526805,"marketCap":319400362950.55},{"date":"2026-02-20","current":31.148176,"twenty":29.777549,"median":35.234954,"eighty":50.526805,"marketCap":318490105234},{"date":"2026-02-27","current":31.852075,"twenty":29.777549,"median":35.181753,"eighty":50.526805,"marketCap":325687471757.28},{"date":"2026-03-06","current":29.253763,"twenty":29.772379,"median":35.070358,"eighty":50.526805,"marketCap":299119723159.18},{"date":"2026-03-13","current":29.124777,"twenty":29.706021,"median":34.983608,"eighty":50.526805,"marketCap":297800850037.39},{"date":"2026-03-20","current":28.184203,"twenty":29.505621,"median":34.905487,"eighty":50.526805,"marketCap":288183473946.5},{"date":"2026-03-27","current":28.940776,"twenty":29.421318,"median":34.860278,"eighty":50.526805,"marketCap":295919433140.34},{"date":"2026-04-02","current":30.757948,"twenty":29.407351,"median":34.837801,"eighty":50.526805,"marketCap":314500010126.83},{"date":"2026-04-10","current":31.009136,"twenty":29.407351,"median":34.765335,"eighty":50.526805,"marketCap":317068408971.87},{"date":"2026-04-15","current":30.409062,"twenty":29.407351,"median":34.711793,"eighty":50.526805,"marketCap":310932657305.97}],"updateTime":1776378783621},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZN\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594184234","title":"「二次議價」猖狂，安徽藥價在「崩塌」","url":"https://stock-news.laohu8.com/highlight/detail?id=2594184234","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594184234?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 18:33","pubTimestamp":1766658788,"startTime":"0","endTime":"0","summary":"“二次议价的返点数还在涨，医院一直在探药企的底线。”多种因素交织发酵下，安徽运行10年之久、围绕“二次议价”形成的微妙平衡生态，正出现“崩塌”迹象。若“明折明扣”，安徽的低价一旦被其他省份采集，将引发连锁降价反应，若“暗折暗扣”，则会影响药企自身的价格体系管理。在安徽，二次议价返点被包装为“投标费率”，药品供应方需签署“自愿让利协议”，以此规避合规风险，这种模式曾维持了相对稳定的运行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225203739a6ceaa1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225203739a6ceaa1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","02196","02607","BK4007","BK4599","LU0154236417.USD","BK4532","AZN","01276","03347","BK4585","NVO","02269","03320","LU1093756325.SGD","IE00BKVL7J92.USD","01801","LU1093756168.USD","09926","01177","03692","09995","00013","IE00BZ1G4Q59.USD","01093"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2594125726","title":"阿斯利康投了！生物製造完成億元融資！","url":"https://stock-news.laohu8.com/highlight/detail?id=2594125726","media":"智药局","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594125726?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 18:30","pubTimestamp":1766658651,"startTime":"0","endTime":"0","summary":"近日，武汉生物制造企业糖智药业完成总金额逾1亿元人民币融资，本轮融资由阿斯利康中金医疗产业基金、华信资本、广新基金、光谷金控及石丰昕汇共同投资。该公司总部位于武汉光谷，在青岛设有研发中心及中试规模的现代化GMP级别实验室，盘锦设有生产工厂，可保障多个项目同时开展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225204045a477a7ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225204045a477a7ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2462157665.USD","LU2456880835.USD","BK4588","LU0320765992.SGD","LU2236285917.USD","BK4585","LU2417539215.USD","BK4007","AZN","LU1829250122.USD","LU0889565916.HKD","LU0109394709.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594257739","title":"阿斯利康罕見病新藥萬諾維獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2594257739","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594257739?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 17:19","pubTimestamp":1766654340,"startTime":"0","endTime":"0","summary":"12月25日，界面新闻从阿斯利康处获悉，其与Ionis公司联合开发的万诺维®（英文商品名：Wainua®，通用名：依普隆特生钠注射液）在中国正式获批，该药物用于治疗成人遗传性转甲状腺素蛋白淀粉样变性多发性神经病（ATTRv-PN）患者。作为中国首个且目前唯一获批用于ATTRv-PN治疗的基因沉默剂，万诺维®的获批为ATTRv-PN患者提供了新的治疗选择，填补了国内在这一领域的治疗空白，有望显著改善患者生活质量，对推动国内罕见病治疗发展具有重要意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225173529a6ce0eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225173529a6ce0eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4568","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","LU1829250122.USD","LU2456880835.USD","BK4007","BK4588","AZN","LU0109394709.USD","LU2417539215.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594236078","title":"萬諾維®在華獲批用於治療成人遺傳性轉甲狀腺素蛋白澱粉樣變性多發性神經病（ATTRv-PN）患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2594236078","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594236078?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 17:10","pubTimestamp":1766653800,"startTime":"0","endTime":"0","summary":"依普隆特生钠是中国首个且目前唯一获批用于ATTRv-PN治疗的基因沉默剂。\" 依普隆特生钠已在美国和欧盟获批用于治疗ATTRv-PN，并正在全球更多国家和地区推进审批进程。依普隆特生钠目前正在开展CARDIO-TTRansform III期临床研究，旨在评估其用于治疗成人转甲状腺素蛋白心脏淀粉样变心肌病的疗效。作为RNA靶向治疗药物，它可在肝脏源头减少TTR蛋白的产生，因而具有潜力用于治疗各类型的转甲状腺素蛋白介导的淀粉样变性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4853711_ZH53711_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","HF","LU0109394709.USD","AZN","LU2236285917.USD","LU2462157665.USD","BK4588","LU0320765992.SGD","BK4082","BK4568","CV","ATTR","BK4585","LU2417539215.USD","LU2456880835.USD","LU0889565916.HKD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594572762","title":"超 70 億美元引進！阿斯利康小核酸療法國內獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2594572762","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594572762?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 16:44","pubTimestamp":1766652263,"startTime":"0","endTime":"0","summary":"12 月 25 日，NMPA 官网显示，阿斯利康的 Eplontersen注射液在国内获批上市。此前，Eplontersen已于 2023 年 12 月获美国 FDA 批准上市，用于治疗成人遗传性转甲状腺素蛋白介导的淀粉样变性多发性神经病。2025 年 3 月，该药在欧盟获批同适应症。2023 年 7 月，双方再次扩大合作，阿斯利康又获得了在拉丁美洲商业化 Eplontersen 的独家权利，此项合作总金额也超过 36 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225172611a6ce05d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225172611a6ce05d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","BK4585","LU2456880835.USD","LU0320765992.SGD","LU0889565916.HKD","BK4568","BK4588","BK4007","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","AZN","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594233412","title":"阿斯利康與第一三共ADC抗癌藥在華獲批第五項適應證","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233412","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594233412?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 16:43","pubTimestamp":1766652224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4007","ADC","BK4568","BK4585","LU0889565916.HKD","LU1829250122.USD","LU2417539215.USD","LU0109394709.USD","LU2462157665.USD","LU2456880835.USD","AZN","LU2236285917.USD","BK4080","BK4231","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594360732","title":"優赫得®在華獲批為首個用於既往在轉移性疾病階段經一種或一種以上內分泌治療進展的HER2低表達或超低表達乳腺癌患者的HER2靶向療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2594360732","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594360732?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 15:30","pubTimestamp":1766647800,"startTime":"0","endTime":"0","summary":"在对HER2超低表达患者进行的探索性分析中，显示HER2超低表达患者群体的试验结果和HER2低表达试验群体的结果具有一致性。经筛查，约85%的HR阳性、HER2阴性转移性乳腺癌患者被检测出有HER2低表达或HER2超低表达3。目前，对于HR阳性转移性乳腺癌患者，不论HER2表达水平如何，内分泌治疗仍被广泛用于早期治疗方案。基于德曲妥珠单抗已取得的临床实践改变，此次获批将为更广泛的HER2表达转移性乳腺癌患者带来亟需的靶向治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4853703_ZH53703_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2417539215.USD","BK4203","LU2462157665.USD","BK4231","BK4585","LU0320765992.SGD","LU2236285917.USD","ORR","ADC","BK4211","PFS","LU0109394709.USD","AZN","LU1829250122.USD","BK4080","HR","BK4162","BK4225","BK4195","IHC","LU2456880835.USD","LU0889565916.HKD","BK4007","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594025721","title":"阿斯利康「戈魯利單抗」國內申報上市，自免雙抗新藥劍指全身型重症肌無力","url":"https://stock-news.laohu8.com/highlight/detail?id=2594025721","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594025721?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 14:33","pubTimestamp":1766644399,"startTime":"0","endTime":"0","summary":"12月24日，据CDE网站显示，阿斯利康的戈鲁利单抗在国内申报上市。根据临床试验进展，推测此次申报的适应症为全身型重症肌无力。全身型重症肌无力是一种罕见、慢性且严重影响生活的自身免疫性神经肌肉疾病，其特征是进行性肌力下降与虚弱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225143342a6cd5c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225143342a6cd5c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","LU2462157665.USD","LU0109394709.USD","LU0889565916.HKD","LU2236285917.USD","LU1829250122.USD","LU0320765992.SGD","LU2456880835.USD","BK4585","AZN","LU2417539215.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594257226","title":"和鉑醫藥牽手百時美施貴寶：超60億合作背後的中國創新藥「逆襲」與全球研發新局","url":"https://stock-news.laohu8.com/highlight/detail?id=2594257226","media":"摩熵医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594257226?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 11:08","pubTimestamp":1766632087,"startTime":"0","endTime":"0","summary":"前几日，和铂医药宣布和百时美施贵宝达成一项长期全球战略合作与许可协议，双方将共同开发新一代多特异性抗体疗法。和铂医药与百时美施贵宝的这次合作，还有今年早些时候和阿斯利康达成的总金额近46亿美元的更大规模战略合作，标志着行业发展的本质变迁。以和铂医药今年三笔重磅合作为例，中国创新药反向授权，从十年前的偶然事件，变成了现在行业常态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225110851a6ccc107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225110851a6ccc107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868837300.USD","BK4588","AZN","BMY","BK4007","LU1718418525.SGD","LU2242646821.SGD","LU0225284248.USD","IE00B2B36J28.USD","LU0868494617.USD","LU0882574055.USD","LU1571399168.USD","LU0985481810.HKD","IE0002141913.USD","LU0321505868.SGD","LU1291159041.SGD","LU1585245621.USD","LU0321505439.SGD","LU2236285917.USD","IE00BFXG1179.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0306806265.USD","LU0225771236.USD","LU0061475181.USD","LU1323610961.USD","LU1670710588.SGD","LU1074936037.SGD","BK4559","LU1829250122.USD","LU0267386448.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU0306807586.USD","LU1989771016.USD","LU0114720955.EUR","BK4532","LU0237698245.USD","LU1670710661.SGD","BK4568","BK4581","LU1430594728.SGD","LU2125154935.USD","LU1670711040.USD","LU2456880835.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1670711123.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593479219","title":"加科思與阿斯利康合作開發KRAS抑制劑 交易總額突破20億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593479219","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593479219?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 19:10","pubTimestamp":1766574606,"startTime":"0","endTime":"0","summary":"本报讯（记者张敏）近日，港股上市公司加科思药业集团有限公司（以下简称“加科思”）发布的公告显示，非全资附属公司北京加科思新药研发有限公司（以下简称“北京加科思”）与AstraZenecaAB（以下简称“阿斯利康”）订立许可与合作协议（以下简称“许可及合作协议”），就开发及商业化泛KRAS抑制剂JAB-23E73展开合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512243600872266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2456880835.USD","BK4588","LU1829250122.USD","BK4007","LU2236285917.USD","LU2462157665.USD","BK4585","AZN","LU0109394709.USD","LU0889565916.HKD","BK4568","LU0320765992.SGD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593421806","title":"阿斯利康(AZN.US)自免雙抗「戈魯利單抗」在華申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593421806","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593421806?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 13:52","pubTimestamp":1766555567,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月24日，CDE网站显示，阿斯利康的戈鲁利单抗在华申报上市。根据临床试验进展，推测此次申报的适应症为全身型重症肌无力。戈鲁利单抗是一种迷你双抗，只包含了靶向C5的抗体重链可变区和与白蛋白特异性结合的抗体片段。全身型重症肌无力是一种罕见、使人衰弱、慢性的自身免疫性神经肌肉疾病，会导致肌肉功能丧失和严重无力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"阿斯利康(AZN.US)自免双抗“戈鲁利单抗”在华申报上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4568","BK4007","BK4585","LU0889565916.HKD","LU1829250122.USD","LU2417539215.USD","LU2462157665.USD","LU0109394709.USD","AZN","LU2236285917.USD","LU2456880835.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593428103","title":"港股異動 | 加科思-B(01167)漲近5% 公司獲阿斯利康近20億美元BD大單 公司稱首付比例均值偏上","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428103","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593428103?lang=zh_tw&edition=fundamental","pubTime":"2025-12-24 10:48","pubTimestamp":1766544525,"startTime":"0","endTime":"0","summary":"加科思将获得1亿美元的首付款，根据开发及商业化进度，还可获得最高19.15亿美元的里程碑付款，以及中国以外市场的净销售额特许权使用费。首付款占总金额比例为5%。在12月22日加科思召开的媒体沟通会上，加科思董事长兼首席执行官王印祥回应称，加科思此次BD交易是中国近几年来处于临床阶段的小分子抗肿瘤药中金额最大的对外授权。王印祥在沟通会上回应了首付款是否低于预期这一问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385315.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2462157665.USD","LU0889565916.HKD","LU2236285917.USD","BK1574","BK1161","LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","01167","AZN","LU2417539215.USD","BK4007","LU1829250122.USD","BK4588","BK4585","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593433677","title":"阿斯利康肺癌試驗藥物組合未達到主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2593433677","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593433677?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 22:12","pubTimestamp":1766412720,"startTime":"0","endTime":"0","summary":"阿斯利康表示，其试验性药物ceralasertib与已获批的癌症治疗药物Imfinzi的组合，在一项针对晚期肺癌的后期临床试验中未能达到主要目标。　　这家英国制药公司周一表示，研究结果显示，与局部晚期或转移性非小细胞肺癌患者的标准疗法相比，ceralasertib组合未能达到总体生存率这一主要目标。　　阿斯利康表示，ceralasertib和Imfinzi的组合总体上耐受性良好，没有出现新的安全性担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-22/doc-inhcsvvf6086289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2236285917.USD","LU2456880835.USD","LU0320765992.SGD","BK4588","LU0889565916.HKD","AZN","LU2462157665.USD","LU1829250122.USD","BK4568","LU0109394709.USD","BK4007","BK4585","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593448816","title":"獲阿斯利康20億美元重金押注，加科思泛KRAS靶向藥成功出海，股價為何不漲反跌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2593448816","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593448816?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 16:55","pubTimestamp":1766393727,"startTime":"0","endTime":"0","summary":"12月21日晚间，加科思药业（01167.HK）宣布，已就其自主研发的泛KRAS（Pan-KRAS）抑制剂JAB-23E73与阿斯利康（AZN.US）达成合作协议。根据协议，阿斯利康将获得该产品在中国以外市场的独家开发和商业化权利。在中国市场，加科思将与阿斯利康共同开发和商业化该产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512223598339468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4588","LU1829250122.USD","LU2462157665.USD","BK4568","AZN","BK4007","LU0889565916.HKD","LU2236285917.USD","LU2456880835.USD","LU0320765992.SGD","LU0109394709.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593171901","title":"阿斯利康入局，Pan-KRAS抑制劑技術路線之爭開始逆轉","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171901","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593171901?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 08:45","pubTimestamp":1766364328,"startTime":"0","endTime":"0","summary":"当阿斯利康以20亿美元接手加科思 Pan-KRAS抑制剂项目的全球开发后，这场竞赛的本质已经发生变化。更重要的是，对阿斯利康来说，一个安全性更好的分子，更有可能在未来KRAS抑制剂联合治疗版图中占据优势。对阿斯利康来说，Pan-KRAS 的终极目标并不仅仅是在某个小人群中证明“能用”，而是成为联用时代的底座。相比之下，加科思 Pan-KRAS抑制剂 采用的是更为传统、成熟的小分子路线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","01167","BK1574","BK4568","LU0109394709.USD","LU0320765992.SGD","LU2236285917.USD","LU1829250122.USD","AZN","BK4585","BK4007","LU0889565916.HKD","LU2456880835.USD","LU2462157665.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593751176","title":"加科思與阿斯利康達成新合作；同仁堂方面發布致歉聲明 | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2593751176","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593751176?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 07:13","pubTimestamp":1766358813,"startTime":"0","endTime":"0","summary":"NO.1丽珠医药NS-041片抑郁症适应证获批开展临床试验12月21日，丽珠医药发布公告，称全资控股子公司收到国家药品监督管理局核准签发的关于NS-041片新增针对治疗抑郁症适应证的《药物临床试验批准通知书》，同意NS-041片新增适应证开展临床试验。资料显示，该药系目前国内唯一获批同时开展癫痫和抑郁症临床研究的KCNQ2/3激动剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512223597678186.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512223597678186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","BK0012","LU2417539215.USD","159938","BK4588","BK4585","BK0097","BK4007","LU2456880835.USD","BK0086","BK0113","BK1574","LU0109394709.USD","BK1161","BK0183","BK0196","BK0239","LU0320765992.SGD","09939","LU2462157665.USD","AZN","600085","LU2236285917.USD","BK0188","BK4568","BK1515","LU0889565916.HKD","BK0028","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593124204","title":"加科思-B(01167)附屬與阿斯利康訂立許可與合作協議，以開發及商業化泛KRAS抑制劑JAB-23E73","url":"https://stock-news.laohu8.com/highlight/detail?id=2593124204","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593124204?lang=zh_tw&edition=fundamental","pubTime":"2025-12-21 19:58","pubTimestamp":1766318290,"startTime":"0","endTime":"0","summary":"加科思-B(01167)公布，该集团的非全资附属公司北京加科思新药研发有限公司与AstraZeneca \nAB(阿斯利康)已订立许可与合作协议，以开发及商业化泛KRAS抑制剂JAB-23E73。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","LU0889565916.HKD","LU2462157665.USD","BK1574","LU0320765992.SGD","BK4568","BK4007","01167","LU0109394709.USD","LU2456880835.USD","LU1829250122.USD","LU2417539215.USD","LU2236285917.USD","BK1161","AZN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592139231","title":"默沙東(MRK.US)、施貴寶(BMY.US)等多家藥企同意下調美國藥價 以換取特朗普政府關税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592139231?lang=zh_tw&edition=fundamental","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4559","LU0320765489.SGD","LU0098860793.USD","SGXZ57979304.SGD","LU1989772923.USD","LU1162221912.USD","LU1261432733.SGD","LU2112291526.USD","LU1989771016.USD","SG9999001176.SGD","LU2125154935.USD","LU1201861249.SGD","BK4550","SG9999015358.SGD","LU0868494617.USD","SG9999014559.SGD","IE00BFXG1179.USD","LU2361044865.SGD","LU0882574055.USD","BK4532","LU1061106388.HKD","LU1699723380.USD","SG9999002232.USD","SG9999014575.USD","LU0980610538.SGD","LU1093756325.SGD","LU2023250843.SGD","SG9999013999.USD","LU1066051498.USD","LU0061475181.USD","LU1291159041.SGD","SG9999001176.USD","SNY","LU1941712348.USD","LU0130102774.USD","LU1116320737.USD","LU0114720955.EUR","BK4581","LU0477156953.USD","LU0265550359.USD","LU1718418525.SGD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0648001328.SGD","LU0985481810.HKD","IE0002141913.USD","BK4585","BK4533","IE000M9KFDE8.USD","LU1066053197.SGD","LU0058720904.USD","LU0965509010.AUD","LU1037948897.HKD","AZN","LU0203345920.USD","LU0321505439.SGD","LU0208291251.USD","LU1868836591.USD","LU2461242641.AUD","LU0985320562.USD","IE00BLSP4239.USD","LU2089984988.USD","LU1571399168.USD","LU1934455277.USD","LU0266013472.USD","LU1066051811.HKD","LU1069347547.HKD","LU0965508806.USD","LU1868837300.USD","IE00B2B36J28.USD","LU2125154778.USD","LU0965509101.SGD","LU0006306889.USD","JNJ","LU0320765646.SGD","LU1670710588.SGD","GSK","LU1868836757.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0225284248.USD","LU1037948541.HKD","LU2106854487.HKD","LU0289739699.SGD","IE00BLSP4452.SGD","LU0211331839.USD","LU0306806265.USD","LU1074936037.SGD","LU0106261372.USD","LU2023250504.SGD","LU1093756168.USD","SG9999002224.SGD","04332","LU2361045086.USD","LU0456855351.SGD","LU1941712264.USD","LU2242646821.SGD","LU1989772840.SGD","BK4534","LU2468319806.SGD","MRK","LU2324357040.USD","LU1983299246.USD","LU0130517989.USD","LU2360032135.SGD","LU0267386448.USD","LU1066051225.USD","ROG","LU0265550946.USD","ABBV","LU0861579265.USD","LU1934455863.HKD","LU1670711123.USD","IE00BBT3K403.USD","LU1868836914.USD","LU1670710661.SGD","LU2133065610.SGD","LU0096364046.USD","BK4588","LU1057294990.SGD","AMGN","LU1023059063.AUD","LU2361044949.HKD","LU1917777945.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1585245621.USD","LU1430594728.SGD","LU1934455194.USD","IE00BN8TJ469.HKD","NVS","LU1035773651.USD","LU1032466523.USD","SG9999001440.SGD","BK4007","IE00BSNM7G36.USD","REGN","LU0321505868.SGD","BK4516","LU1929549753.HKD","IE00BJT1NW94.SGD","LU0306807586.USD","LU0965509283.SGD","GILD","IE00B4R5TH58.HKD","LU1974910355.USD","LU0237698245.USD","LU0203347892.USD","LU0225771236.USD","SG9999014542.SGD","LU1323610961.USD","SG9999014567.USD","LU0238689110.USD","LU0234572021.USD","BMY","LU0070302665.USD","SG9999015341.SGD","LU1868837136.USD","LU1116320901.HKD","LU1670711040.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2592199939","title":"阿斯利康甲磺酸奧希替尼片啓動II期臨床 適應症為不適合或拒絕化療的EGFR常見突變陽性III期不可切除NSCLC患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2592199939","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592199939?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 18:03","pubTimestamp":1766138580,"startTime":"0","endTime":"0","summary":"本次试验目的是评估不适合或拒绝化疗的EGFRm阳性III期不可切除NSCLC患者在放疗前使用奥希替尼作为诱导治疗及在放疗后继续使用奥希替尼直至疾病进展的有效性。甲磺酸奥希替尼片为化学药物，适应症为不适合或拒绝化疗的EGFR常见突变阳性III期不可切除NSCLC患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219185751a6b6da17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219185751a6b6da17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4568","LU0320765992.SGD","LU2417539215.USD","III","LU2462157665.USD","LU2236285917.USD","AZN","BK4588","BK4585","LU0109394709.USD","LU0889565916.HKD","BK4134","LU2456880835.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592954199","title":"荷聲科技完成Pre-A輪融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2592954199","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592954199?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 15:07","pubTimestamp":1766128034,"startTime":"0","endTime":"0","summary":"阿斯利康中金医疗产业基金近日宣布完成对杭州荷声科技有限公司Pre-A轮融资。中金资本董事总经理沈圆江表示：“荷声科技自成立以来，专注于突破高端超声核心技术，展现出显著成长潜力，同时在新一代超声系统发展趋势中具备前瞻性布局。本轮Pre-A融资完成，是对其技术实力和行业前景的积极认可。我们相信，在产业资源的协同下，荷声科技将稳步推进产品落地与规模化应用，持续引领中国高端医疗超声创新发展。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152604a6b5f722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152604a6b5f722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2236285917.USD","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","LU2456880835.USD","LU0889565916.HKD","LU2462157665.USD","LU0320765992.SGD","BK4568","BK4585","BK4588","AZN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":197,"code":"91000000","status":"200"}]}}